Inivata
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis
Inivata has raised €46M across 1 funding round, most recently a Series B round in Jan 2019. Based in Cambridge, UK; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€46M
€45,938,865
Funding rounds
1
Investors
0
distinct backers
Active since
2019-01
latest 2019-01
Funding by year
EUR raised per yearInivata — funding by year — interactive chart.
Data table
| Inivata — funding by year | |
|---|---|
| 2018 | €46M |
Signals
Medium confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series B | €46M | — | View deal → |